Alexandria Real Estate Equities, Inc. ARE has entered into an agreement with Autolus Therapeutics PLC AUTL to construct and develop a build-to-suit project in Rockville, MD.
The facility, spanning 85,000 square feet of space, will be situated in the Shady Grove Life Sciences Center. It will also serve as Autolus’ first commercial-scale manufacturing site.
Specifically, the clinical-stage biopharmaceutical company that develops next-generation programmed T cell therapies has signed a long-term lease to occupy the entire building. It is expected to be ready for occupancy in 2021.
The property will also serve as the company’s U.S headquarter, housing research and development, commercial as well as corporate units. Further, it is projected to have an annual production capacity of 5,000 T cell therapies.
Per Autolus management, the facility will enable it to provide large-scale and economical advanced T cell therapies to patients. For Alexandria, the long-term lease and full occupancy reflects the strength of this property. In addition, it is anticipated to boost leasing and occupancy level for the company.
Notably, university-based life-science real estate is a new zone of investment which has grabbed attention. Increasing longevity of the aging U.S. population, along with biopharma drug development growth opportunities, has spurred demand for institutional life-science and medical-market properties.
Hence, focus on collaborative life-science and technology campuses will offer Alexandria the prospect to capitalize on the growing healthcare-driven research and development, supported by top-tier research universities.
Also, the company’s existing active development and redevelopment pipeline is significant. In fact, the company has 2.6 million RSF targeted for delivery by 2019. However, an extensive development pipeline increases operational risks, and makes the company vulnerable to rising construction costs and lease-up concerns.
Moreover, shares of this Zacks Rank #3 (Hold) company have inched up 1.9%, outperforming its industry’s gain of 0.7%, over the past month.
Stocks to Consider
OUTFRONT Media Inc. OUT sports a Zacks Rank of 1 (Strong Buy), currently. The company’s funds from operation (FFO) per share estimates for 2018 remained unchanged at $2.09 in a month’s time. Its shares have appreciated 9.3% over the past three months. You can see the complete list of today’s Zacks #1 Rank stocks here.
Cousins Properties Incorporated CUZ carries a Zacks Rank of 2 (Buy), at present. The company’s FFO per share estimates for 2018 remained unrevised at 62 cents, over the past month. Its shares have rallied 3.2% over the past month.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
OUTFRONT Media Inc. (OUT) : Free Stock Analysis Report
Alexandria Real Estate Equities, Inc. (ARE) : Free Stock Analysis Report
Cousins Properties Incorporated (CUZ) : Free Stock Analysis Report
Autolus Therapeutics PLC Sponsored ADR (AUTL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research